Fluorescence Guided Surgery Systems Market, By Type (SPY System, PDE System, VS3 Iridium System, and Other Types), By Surgery (Open Surgery and Laparoscopy/Endoscopy), By Application (Cancer Surgeries, Cardiovascular Surgeries, and Other Applications), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In : Oct 2022

Code : CMI5286

Pages :169

Formats :

Excel and PDF

Industry : Medical Devices

Market Challenges And Opportunities

Global Fluorescence Guided Surgery Systems Market Drivers:

Increasing prevalence of chronic disease, such as cardiac diseases and cancer, around the world is expected to augment growth of the global fluorescence guided surgery systems market over the forecast period. Fluorescence guided surgery (FGS) can be used to define the tumor location and margins during the procedure. According to the World Health Organization (WHO), cancer is a leading cause of death across the globe, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. The most common cancers are breast, lung, prostate, and colon and rectum cancers. This in turn is expected to propel the market growth.

Increase in usage of advanced imaging techniques is expected to boost the growth of the global fluorescence guided surgery systems market over the forecast period. For instance, FGS is an imaging technique that helps surgeon to visualise different structures and types of tissue during a surgical procedure that may not be as visible under white light conditions. In October 2021, Delray Medical Center published a breakthrough study focusing on 5ALA (fluorescent guided surgery) for glioblastomas with the team at Mount Sinai Hospital.

Global Fluorescence Guided Surgery Systems Market Opportunities:

Rise in demand for fluorescence guided surgery systems is expected to offer lucrative growth opportunities for players in the fluorescence guided surgery systems market. For instance, FGS surgery has provided highly satisfactory results for oncology and reconstructive surgery. FGS can potentially change the future of reconstructive and oncological procedures. Thus, there is an increase in demand for fluorescence guided surgery systems around the world, driving the growth of the fluorescence guided surgery systems market.

Rise in investments in research and development activities is expected to provide significant growth opportunities for players in the global fluorescence guided surgery systems market. For instance, in April 2021, OnLume Inc. (a medical imaging company) received a US$ 2 million grant from the National Cancer Institute (NCI) to advance the development of its proprietary device for FGS. OnLume’s FGS technique helps improve precision, which can lead to better patient outcomes, lower costs, and lower morbidity.

Global Fluorescence Guided Surgery Systems Market Restraints:

Side effects associated with fluoroscopy are expected to hamper the growth of the fluorescence guided surgery systems market. For instance, fluoroscopy carries the same risks as other X-ray procedures due to radiation exposure. Risks from exposure to ionizing radiation may include radiation-induced injuries to the skin and underlying tissues (burns), which occur shortly after the exposure, and. radiation-induced cancers, which may occur sometime later in life.

Lack of skilled professionals (to handle and operate fluorescence imaging system) is expected to hinder growth of the global fluorescence guided surgery systems market. For instance, rapid technological changes or advances in the healthcare field have increased the demand for skilled professionals. Moreover, effective implementation and understanding innovative technologies in fluorescence imaging is crucial while performing the surgery. Thus, there is need for skilled professionals to handle and operate fluorescence imaging system.